PMID- 29720875 OWN - NLM STAT- PubMed-not-MEDLINE LR - 20220330 IS - 1177-889X (Print) IS - 1177-889X (Electronic) IS - 1177-889X (Linking) VI - 12 DP - 2018 TI - Patient engagement in type 2 diabetes mellitus research: what patients want. PG - 595-606 LID - 10.2147/PPA.S159707 [doi] AB - BACKGROUND: As patients are the ultimate stakeholder in their health, their perspectives should be included along with researchers, providers, and funders of research design, execution, and interpretation. Despite the high prevalence of type 2 diabetes mellitus (T2DM), patients are rarely directly included in these decisions. PURPOSE: We sought to determine areas of research most important to patients with T2DM, identify ways through which patients with T2DM want to engage in research, and evaluate online patient research networks as a source for obtaining patient perspectives on research engagement. PATIENTS AND METHODS: This study used an online patient community forum (PatientsLikeMe) to host two asynchronous moderated discussions, each with three to four prompted discussion posts. A qualitative summary of themes was derived from the posts. RESULTS: Eighty-eight participants with T2DM took part. Participants were mostly white (86%), averaged 58.6 years of age, half were female (50%), and over half (62%) resided in the US. Research priorities included managing T2DM with comorbidities, controlling blood sugar levels, finding a cure, and understanding causes of T2DM. Participants wanted to see direct applications of research to their lives. Clinical research was perceived to have overly restrictive eligibility criteria and to measure outcome sets that do not adequately address patient health concerns. Participants indicated broad interest in partnering in research and a willingness to apply their skills and educational background to specific stages in the research process. CONCLUSION: Patients with T2DM would like researchers to address outcomes that have meaning in patients' daily lives. Initiatives to involve patients in research should leverage and enable patients to contribute as participants, advisors, or co-investigators, going beyond research topic prioritization to full participation throughout the research process based on their abilities and interest. This study provides support for the use of online patient research network discussions to generate rich qualitative data to engage patients in research. FAU - Simacek, Kristina F AU - Simacek KF AD - PatientsLikeMe, Cambridge, MA, USA. FAU - Nelson, Tanya AU - Nelson T AD - Janssen Scientific Affairs, LLC, Raritan, NJ, USA. FAU - Miller-Baldi, Mignon AU - Miller-Baldi M AD - Janssen Medical Information Center, Titusville, NJ, USA. FAU - Bolge, Susan C AU - Bolge SC AD - Janssen Scientific Affairs, LLC, Raritan, NJ, USA. LA - eng PT - Journal Article DEP - 20180420 PL - New Zealand TA - Patient Prefer Adherence JT - Patient preference and adherence JID - 101475748 PMC - PMC5918623 OTO - NOTNLM OT - diabetes mellitus OT - patient engagement OT - patient involvement OT - qualitative research OT - research priorities OT - social media OT - social networking COIS- Disclosure KFS is an employee of PLM and holds stock options in the company. SCB, MBB, and TN are employees of the Janssen Pharmaceutical Companies of Johnson & Johnson and stockholders in parent company Johnson & Johnson. The authors report no other conflicts of interest in this work. EDAT- 2018/05/04 06:00 MHDA- 2018/05/04 06:01 PMCR- 2018/04/20 CRDT- 2018/05/04 06:00 PHST- 2018/05/04 06:00 [entrez] PHST- 2018/05/04 06:00 [pubmed] PHST- 2018/05/04 06:01 [medline] PHST- 2018/04/20 00:00 [pmc-release] AID - ppa-12-595 [pii] AID - 10.2147/PPA.S159707 [doi] PST - epublish SO - Patient Prefer Adherence. 2018 Apr 20;12:595-606. doi: 10.2147/PPA.S159707. eCollection 2018.